Literature DB >> 28870692

Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.

Alexandra M Haugh1, Bin Zhang1, Victor L Quan1, Erin M Garfield1, Jeffrey A Bubley1, Emily Kudalkar1, Anna Elisa Verzi1, Kara Walton1, Timothy VandenBoom1, Emily A Merkel1, Christina Y Lee1, Timothy Tan2, Maria Cristina Isales2, Betty Y Kong1, Alexander T Wenzel1, Christopher G Bunick3, Jaehyuk Choi4, Jeffrey Sosman5, Pedram Gerami6.   

Abstract

Acral melanoma is distinct from melanoma of other cutaneous sites, yet there is considerable variation within this category. To better define this variation, we assessed melanomas occurring on dorsal (n = 21), volar (n = 9), and subungual/interdigital (n = 13) acral skin as well as acral nevi (n = 24) for clinical, histologic, and molecular features. Melanomas on dorsal acral surfaces demonstrated clear differences compared with volar and subungual/interdigital melanomas. The latter two groups exhibited significantly less frequent BRAF mutations (P = 0.01), were significantly less likely to have the superficial spreading histologic subtype (P = 0.01), occurred in older patients (P = 0.05), and had more frequent involvement in non-Caucasians (P = 0.01). These differences can be explained by differing levels of UV exposure. Subungual/interdigital melanomas had the most diverse group of oncogenic mutations including PIK3CA (2/13), STK11 (2/13), EGFR (1/13), FGFR3 (1/13), and PTPN11 (1/13). In addition, subungual/interdigital melanomas had a significantly higher frequency of copy number aberrations (67%) than other subgroups (P = 0.02), particularly in CDK4 and cyclin D1, and were less likely to have BRAF mutations or a superficial spreading histologic subtype (P = 0.05) compared with volar acral melanomas. Although based on a limited sample size, differences between volar and subungual/interdigital melanomas in our study may be the result of differing levels of UV exposure.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28870692     DOI: 10.1016/j.jid.2017.08.022

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Subungual melanoma.

Authors:  Bijan Koushk Jalali; Alexander Kreuter
Journal:  CMAJ       Date:  2018-08-27       Impact factor: 8.262

2.  Clinical and genetic analysis of melanomas arising in acral sites.

Authors:  Anne Zaremba; Rajmohan Murali; Philipp Jansen; Inga Möller; Antje Sucker; Annette Paschen; Lisa Zimmer; Elisabeth Livingstone; Titus J Brinker; Eva Hadaschik; Cindy Franklin; Alexander Roesch; Selma Ugurel; Dirk Schadendorf; Klaus G Griewank; Ioana Cosgarea
Journal:  Eur J Cancer       Date:  2019-08-14       Impact factor: 9.162

3.  The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.

Authors:  Xiaoting Wei; Di Wu; Hang Li; Rui Zhang; Yu Chen; Hong Yao; Zhihong Chi; Xinan Sheng; Chuanliang Cui; Xue Bai; Zhonghui Qi; Ke Li; Shijie Lan; Lizhu Chen; Rui Guo; Xinyu Yao; Lili Mao; Bin Lian; Yan Kong; Jie Dai; Bixia Tang; Xieqiao Yan; Xuan Wang; Siming Li; Li Zhou; Charles M Balch; Lu Si; Jun Guo
Journal:  Ann Surg Oncol       Date:  2020-04-06       Impact factor: 5.344

4.  Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.

Authors:  Avani M Kolla; Gerardo A Vitiello; Erica B Friedman; James Sun; Aishwarya Potdar; Hala Daou; Norma E Farrow; Clara R Farley; John T Vetto; Dale Han; Marvi Tariq; Georgia M Beasley; Carlo M Contreras; Michael Lowe; Jonathan S Zager; Iman Osman; Russell S Berman; Tracey N Liebman; Jennifer A Stein; Ann Y Lee
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

5.  Does acral melanoma need a distinctive prognostic staging system?

Authors:  Cristina Carrera; Sebastian Podlipnik
Journal:  Br J Dermatol       Date:  2022-05-03       Impact factor: 11.113

Review 6.  Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.

Authors:  Jianping Gui; Zhen Guo; Di Wu
Journal:  J Transl Med       Date:  2022-08-16       Impact factor: 8.440

Review 7.  Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease.

Authors:  Patricia Basurto-Lozada; Christian Molina-Aguilar; Carolina Castaneda-Garcia; Martha Estefania Vázquez-Cruz; Omar Isaac Garcia-Salinas; Alethia Álvarez-Cano; Héctor Martínez-Said; Rodrigo Roldán-Marín; David J Adams; Patricia A Possik; Carla Daniela Robles-Espinoza
Journal:  Pigment Cell Melanoma Res       Date:  2020-06-17       Impact factor: 4.693

Review 8.  More than just acral melanoma: the controversies of defining the disease.

Authors:  Sara S Bernardes; Ingrid Ferreira; David E Elder; Aretha B Nobre; Héctor Martínez-Said; David J Adams; Carla Daniela Robles-Espinoza; Patricia A Possik
Journal:  J Pathol Clin Res       Date:  2021-07-02

9.  Establishment of cultured primary acral melanoma cells and animal models for Chinese patients.

Authors:  Rui Hu; Shuang Zhao; Juan Su; Xiang Chen; Mingzhu Yin
Journal:  Pigment Cell Melanoma Res       Date:  2021-06-28       Impact factor: 4.159

10.  Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival.

Authors:  Takamichi Ito; Yumiko Kaku-Ito; Maho Murata; Kazuhisa Furue; Che-Hung Shen; Yoshinao Oda; Masutaka Furue
Journal:  J Clin Med       Date:  2020-03-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.